AtriCure (ATRC) Earnings Date, Estimates & Call Transcripts $31.50 -0.04 (-0.13%) (As of 12/17/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends AtriCure Latest Earnings SummaryActual EPS (Oct. 29) -$0.17 Beat By $0.02 Consensus EPS (Oct. 29) -$0.19 AtriCure issued Q3 2024 earnings on October 29, 2024, reporting an EPS of -$0.17, which topped the consensus estimate of -$0.19 by $0.02. Quarterly revenue rose 17.9% year-over-year to $115.91 million, above analysts' expectations of $112.23 million. With a trailing EPS of -$0.83, AtriCure's earnings are expected to grow next year, from ($0.72) to ($0.63) per share. Conference CallConference Call TranscriptEarnings Press ReleaseEarnings Slide DeckSEC 10-Q/10-K FilingPowered by Get AtriCure Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AtriCure and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataATRC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ATRC Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. AtriCure Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241-$0.24-$0.24-$0.24 Q2 20241-$0.23-$0.23-$0.23 Q3 20241-$0.20-$0.20-$0.20 Q4 20241-$0.16-$0.16-$0.16 FY 20244($0.83)($0.83) ($0.83) AtriCure Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails10/29/2024Q3 2024-$0.19-$0.17+$0.02-$0.17$112.23M$115.91M7/30/2024Q2 2024-$0.17-$0.17--$0.17$116.24M$116.27M5/1/2024Q1 2024-$0.23-$0.25 -$0.02-$0.22$106.86M$108.90M2/15/2024Q4 2023-$0.22-$0.21+$0.01-$0.21$103.68M$106.50M11/1/2023Q3 2023-$0.30-$0.20+$0.10-$0.20$96.65M$98.29M7/25/2023Q2 2023-$0.27-$0.12+$0.15-$0.13$97.55M$100.92M Get the Latest News and Ratings for ATRC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AtriCure and its competitors with MarketBeat's FREE daily newsletter. 5/2/2023Q1 2023-$0.34-$0.23+$0.11-$0.32$87.53M$93.49M2/21/2023Q4 2022-$0.18-$0.09+$0.09-$0.09$87.90M$88.00M AtriCure Earnings - Frequently Asked Questions When did AtriCure announce their last quarterly earnings? AtriCure (NASDAQ:ATRC) last announced its quarterly earning data on Tuesday, October 29, 2024. Learn more on ATRC's earnings history. What guidance has AtriCure issued on next quarter's earnings? AtriCure issued an update on its FY 2024 earnings guidance on Tuesday, October, 29th. The company provided earnings per share (EPS) guidance of -0.800--0.740 for the period, compared to the consensus earnings per share estimate of -0.790. The company issued revenue guidance of $459.0 million-$462.0 million, compared to the consensus revenue estimate of $458.1 million. Did AtriCure beat their earnings estimates last quarter? In the previous quarter, AtriCure (NASDAQ:ATRC) reported ($0.17) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.19) by $0.02. Learn more on analysts' earnings estimate vs. ATRC's actual earnings. How can I listen to AtriCure's earnings conference call? The conference call for AtriCure's latest earnings report can be listened to online. Listen to Conference Call How can I read AtriCure's conference call transcript? The conference call transcript for AtriCure's latest earnings report can be read online. Read Transcript How can I view AtriCure's earnings report? AtriCure's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does AtriCure generate each year? AtriCure (NASDAQ:ATRC) has a recorded annual revenue of $447.57 million. How much profit does AtriCure generate each year? AtriCure (NASDAQ:ATRC) has a recorded net income of -$30.44 million. ATRC has generated -$0.83 earnings per share over the last four quarters. What is AtriCure's EPS forecast for next year? AtriCure's earnings are expected to grow from ($0.72) per share to ($0.63) per share in the next year. More Earnings Resources from MarketBeat Related Companies Integer Earnings Integra LifeSciences Earnings Alphatec Earnings Orthofix Medical Earnings Surmodics Earnings AngioDynamics Earnings Accuray Earnings Rockwell Medical Earnings ReShape Lifesciences Earnings Abbott Laboratories Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now This page (NASDAQ:ATRC) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AtriCure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AtriCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
